Printer-friendly version

British Columbia, like its neighbours Alberta and Saskatchewan, is enjoying robust economic growth and prosperity. British Columbia is currently faced with an extraordinary opportunity. The province can create a tax advantage over all other provinces, including Alberta, by simply maintaining current per person spending, acknowledging more realistic revenue expectations, and focusing energy and resources on a three-year tax relief plan. The result would be a marked tax advantage for British Columbia in both personal and business taxes, which would improve the incentives for work, savings, investment, and entrepreneurship.

Printer-friendly version

The index published in Economic Freedom of the World measures the degree to which the policies and institutions of countries support economic freedom. The cornerstones of economic freedom are personal choice, voluntary exchange, freedom to compete, and security of privately owned property.

Printer-friendly version

This report is the third instalment in ongoing research to assess the performance of labour markets and explain why results differ among jurisdictions. Such indicators of labour performance as job creation, unemployment, and productivity are used to assess Canadian provincial and US state labour market performance.

Printer-friendly version

In July 2007, the Canadian Medical Association Journal (CMAJ) published articles by Irfan Dhalla and François Béland denying that the growth of government health expenditures in Canada is unsustainable. Methodological and conceptual errors in their articles produced invalid analyses and grossly misleading conclusions about the sustainability of government health spending under the Medicare policy model.

Printer-friendly version

Canadians pay much more than Americans for generic drugs because government policies in Canada distort the market for prescription medicines. In currency-equivalent terms, Canadian retail prices for generic prescription drugs in 2006 were on average 115% higher than retail prices observed in the United States for identical drugs. A previous analysis using 2003 data found that prices for generic drugs were 78% higher in Canada. By contrast, Canadian retail prices for brand-name drugs were on average 51% below US prices for identical drugs in 2006. In 2003, the prices for brand-name drugs was 43% lower in Canada on average.

Printer-friendly version

The shootings at Montreal's Dawson College in September 2006 reignited the controversy over the firearms registry. This paper is a timely effort to evaluate the effectiveness of the 1995 firearm legislation. In 1995, the government assumed that, by controlling the availability of firearms, the registry would reduce total criminal violence, not just gun violence, suicide and domestic abuse.

Printer-friendly version

The purpose of this publication is to contribute to the public dialogue about drug safety regulation and to raise the awareness of the general public about some important but perhaps underappreciated concepts about risk that should be part of the decision-making process when drug-safety standards are defined.